Literature DB >> 16432181

Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice.

Randall J Roper1, Laura L Baxter, Nidhi G Saran, Donna K Klinedinst, Philip A Beachy, Roger H Reeves.   

Abstract

Trisomy 21 is the cause of Down [corrected] syndrome (DS) which is characterized by a number of phenotypes, including a brain which is small and hypocellular compared to that of euploid individuals. The cerebellum is disproportionately reduced. Ts65Dn mice are trisomic for orthologs of about half of the genes on human chromosome 21 and provide a genetic model for DS. These mice display a number of developmental anomalies analogous to those in DS, including a small cerebellum with a significantly decreased number of both granule and Purkinje cell neurons. Here we trace the origin of the granule cell deficit to precursors in early postnatal development, which show a substantially reduced mitogenic response to Hedgehog protein signaling. Purified cultures of trisomic granule cell precursors show a reduced but dose-dependent response to the Sonic hedgehog protein signal in vitro, demonstrating that this is a cell-autonomous deficit. Systemic treatment of newborn trisomic mice with a small molecule agonist of Hedgehog pathway activity increases mitosis and restores granule cell precursor populations in vivo. These results demonstrate a basis for and a potential therapeutic approach to a fundamental aspect of CNS pathology in DS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432181      PMCID: PMC1360600          DOI: 10.1073/pnas.0510750103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  BrainImageJ: a Java-based framework for interoperability in neuroscience, with specific application to neuroimaging.

Authors:  Y R Ng; S Shiffman; T J Brosnan; J M Links; L S Beach; N S Judge; Y Xu; U V Kelkar; A L Reiss
Journal:  J Am Med Inform Assoc       Date:  2001 Sep-Oct       Impact factor: 4.497

2.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.

Authors:  Bruce F Pennington; Jennifer Moon; Jamie Edgin; Jennifer Stedron; Lynn Nadel
Journal:  Child Dev       Date:  2003 Jan-Feb

3.  Directed differentiation of embryonic stem cells into motor neurons.

Authors:  Hynek Wichterle; Ivo Lieberam; Jeffery A Porter; Thomas M Jessell
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

4.  Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.

Authors:  J T Richtsmeier; L L Baxter; R H Reeves
Journal:  Dev Dyn       Date:  2000-02       Impact factor: 3.780

5.  Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice.

Authors:  M A Kurt; D C Davies; M Kidd; M Dierssen; J Flórez
Journal:  Brain Res       Date:  2000-03-06       Impact factor: 3.252

6.  Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches.

Authors:  Robert Machold; Shigemi Hayashi; Michael Rutlin; Mandar D Muzumdar; Susana Nery; Joshua G Corbin; Amel Gritli-Linde; Tammy Dellovade; Jeffery A Porter; Lee L Rubin; Henryk Dudek; Andrew P McMahon; Gord Fishell
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

7.  Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion.

Authors:  J D Cooper; A Salehi; J D Delcroix; C L Howe; P V Belichenko; J Chua-Couzens; J F Kilbridge; E J Carlson; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.

Authors:  L L Baxter; T H Moran; J T Richtsmeier; J Troncoso; R H Reeves
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

9.  Small molecule modulation of Smoothened activity.

Authors:  James K Chen; Jussi Taipale; Keith E Young; Tapan Maiti; Philip A Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

10.  Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine.

Authors:  J Taipale; J K Chen; M K Cooper; B Wang; R K Mann; L Milenkovic; M P Scott; P A Beachy
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

View more
  89 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

Review 2.  Down syndrome: from understanding the neurobiology to therapy.

Authors:  Katheleen Gardiner; Yann Herault; Ira T Lott; Stylianos E Antonarakis; Roger H Reeves; Mara Dierssen
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

Review 3.  The cognitive phenotype of Down syndrome: insights from intracellular network analysis.

Authors:  Avi Ma'ayan; Katheleen Gardiner; Ravi Iyengar
Journal:  NeuroRx       Date:  2006-07

4.  Strategy adoption and locomotor adjustment in obstacle clearance of newly walking toddlers with Down syndrome after different treadmill interventions.

Authors:  Jianhua Wu; Dale A Ulrich; Julia Looper; Chad W Tiernan; Rosa M Angulo-Barroso
Journal:  Exp Brain Res       Date:  2007-12-07       Impact factor: 1.972

5.  A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog.

Authors:  Randall J Roper; Justin F VanHorn; Colyn C Cain; Roger H Reeves
Journal:  Mech Dev       Date:  2008-11-21       Impact factor: 1.882

Review 6.  SHH pathway and cerebellar development.

Authors:  Catherine Vaillant; Denis Monard
Journal:  Cerebellum       Date:  2009-02-18       Impact factor: 3.847

Review 7.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

8.  Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model.

Authors:  Ishita Das; Joo-Min Park; Jung H Shin; Soo Kyeong Jeon; Hernan Lorenzi; David J Linden; Paul F Worley; Roger H Reeves
Journal:  Sci Transl Med       Date:  2013-09-04       Impact factor: 17.956

Review 9.  Molecular basis of pharmacotherapies for cognition in Down syndrome.

Authors:  Katheleen J Gardiner
Journal:  Trends Pharmacol Sci       Date:  2009-12-04       Impact factor: 14.819

10.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.